Skip to content

Elicio Therapeutics, Inc.: filings

Every Elicio Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 22 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 2026371080001601485-26-000056
10-Q2026-05-11fiscal Q1 202637780001601485-26-000042
10-K2026-03-12fiscal FY 202543860001601485-26-000027
10-Q2025-11-13fiscal Q3 2025401180001601485-25-000124
10-Q2025-08-07fiscal Q2 2025411160001601485-25-000111
10-Q2025-05-13fiscal Q1 202540840001601485-25-000074
10-K2025-03-31fiscal FY 202443880001601485-25-000049
10-Q2024-11-13fiscal Q3 2024411210001601485-24-000075
10-Q2024-08-13fiscal Q2 2024411150001601485-24-000045
10-Q2024-05-15fiscal Q1 202441870001601485-24-000033
10-K2024-03-29fiscal FY 202343870001601485-24-000023
10-Q2023-11-13fiscal Q3 2023401190001601485-23-000082
10-Q2023-08-14fiscal Q2 2023401130001601485-23-000052
10-Q2023-05-10fiscal Q1 202338790001601485-23-000035
10-K2023-03-17fiscal FY 202247950001601485-23-000011
10-Q2022-11-14fiscal Q3 2022411150001601485-22-000070
10-Q2022-08-15fiscal Q2 2022421130001601485-22-000066
10-Q2022-05-16fiscal Q1 202242870001601485-22-000037
10-K2022-03-30fiscal FY 202147950001601485-22-000022
10-Q2021-11-12fiscal Q3 2021431190001601485-21-000068
10-Q2021-08-12fiscal Q2 2021431210001601485-21-000047
10-Q2021-05-17fiscal Q1 202143890001601485-21-000017

Inspect the source

Entity
Elicio Therapeutics, Inc. / CIK 0001601485
Captured
2026-09-20T09:25:24.218Z
SEC response SHA-256
4658ce667672a29d8217f92b7294115160c0f599bb2841d4ee3a3278d5255354

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001601485.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))